Dosidal · Switzerland

NovoSeven, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:58693 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 58693
atc: B02BD08
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2009-03-27
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: B02BD08
authorisation_number: 58693
form: PULMJ
holder: Novo Nordisk Pharma AG
holder_partner_nr: 1000306
it_number: 06.01.1.
name: NovoSeven, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
01AyYG6Ctn_xeHX-IBXYviClEZXU2Ub_rVIESeeZAfUCS1PNAGyj2Te-eH9b9WhLwM2tMLkteHNmGeW8bCs_DQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:58693 · Related records in other markets · Dosidal